SELLAS Life Sciences (SLS) Tax Provisions (2013 - 2019)
SELLAS Life Sciences (SLS) reported Tax Provisions of -$81000.0 for Q4 2019, up 94.74% year-over-year from -$41593.1 in Q4 2018, and up 94.74% on a QoQ basis from -$1.5 million in Q4 2018.
SELLAS Life Sciences (SLS) has 4 years of Tax Provisions data on file, last reported at -$81000.0 in Q4 2019.
- Quarterly Tax Provisions rose 94.74% year-over-year to -$81000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$1.6 million (down 24.29% YoY) and the FY2021 annual result came in at -$237000.0, down 1294.12% from the prior year.
- Tax Provisions climbed to -$81000.0 in Q4 2019 per SLS's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Tax Provisions topped out at $163000.0 in Q2 2018 and bottomed at -$1.5 million in Q4 2018.
- The 3-year median for Tax Provisions is $68000.0 (2017), against an average of -$201000.0.
- The widest annual swing landed in 2018, when Tax Provisions plunged 2210.96%; it then surged 94.74% in 2019.
- Tracing SLS's Tax Provisions over 3 years: stood at $73000.0 in 2017, then sank by 2210.96% to -$1.5 million in 2018, then surged by 94.74% to -$81000.0 in 2019.
- Per Business Quant, the three latest SLS Tax Provisions figures stand at -$81000.0 (Q4 2019), -$1.5 million (Q4 2018), and $163000.0 (Q2 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -81,000.00 |
| Dec 31, 2018 | -1.54 Mn |
| Jun 30, 2018 | 163,000.00 |
| Dec 31, 2017 | 73,000.00 |
| Sep 30, 2017 | 63,000.00 |
| Jun 30, 2017 | 117,000.00 |
| Dec 31, 2013 | 1.11 Mn |
| Sep 30, 2013 | 1.16 Mn |
| Jun 30, 2013 | 1.54 Mn |
| Mar 31, 2013 | -2.76 Mn |